Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus

  • 109 Accesses

  • 31 Citations

Summary

Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients share many clinical and biochemical characteristics. However, sural nerve biopsies from patients with advanced and chronic neuropathy show ultrastructural differences between these two groups. We investigated whether at a subclinical stage of the illness, when Type 1 and Type 2 diabetic patients are clinically uniform and the histopathological nerve alterations are not advanced, comparison between the two diabetes groups might show differences in nerve fibre involvement related to the different pathogeneses of the neuropathies. A total of 88 diabetic patients (52 Type 1 and 36 Type 2), with a subclinical form of polyneuropathy were selected. The clinical neurophysiological examination consisted of motor and sensory nerve conduction studies, Hoffmann (H)-reflex, single fibre electromyography and static as well as dynamic pupillometry. With regard to clinical neurophysiological abnormalities, the severity of the polyneuropathy appeared to be equal in both groups. Despite the absence of clinical symptoms the neurophysiological abnormalities were pronounced and it was impossible to differentiate Type 1 diabetic patients from Type 2 diabetic patients on a clinical neurophysiology basis when correcting for differences in age, height, and duration of illness. In the Type 1 diabetic group as well as in the Type 2 diabetic group the autonomic nerve fibres and nerves in the legs were more frequently affected than the thick myelinated nerves in the arms. These findings do not support the assumption that there is a difference in the manifestation of polyneuropathy between Type 1 and Type 2 diabetic patients.

References

  1. 1.

    Brown MJ, Asbury AK (1984) Diabetic neuropathy. Ann Neurol 15: 2–12

  2. 2.

    Johnson PC, Doll SC, Cromey DW (1986) Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450–457

  3. 3.

    Dyck PJ, Karnes JL, O'Brien P, Okazaki H (1986) The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 19: 440–449

  4. 4.

    Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R (1986) Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425–439

  5. 5.

    Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diab Care 1: 168–188, 252–263

  6. 6.

    Sima AAF, Nathaniel V, Bril V (1988) Histopathological heterogeneity of neuropathy in IDDM and non-IDDM, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349–364

  7. 7.

    Dyck PJ, Karnes J, Lais EP (1984) Pathologic alteration of the peripheral nervous system of humans. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 760–870

  8. 8.

    Gregersen G (1967) Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology 17: 972–980

  9. 9.

    Dyck PJ (1988) Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21–32

  10. 10.

    Bril V, Sima AAF, Werb MR, Greene DA (1985) Motor electrophysiological studies in diabetic patients. Electro Clin Neurophysiol 61: S147

  11. 11.

    Troni W, Cantello R, Rainero E (1983) The use of the H-reflex in serial evaluation of nerve conduction velocity. Electro Clin Neurophysiol 55: 82–90

  12. 12.

    Shields RW (1987) SFEMG is a sensitive indicator of axonal degeneration in diabetes. Neurology 37: 1394–1397

  13. 13.

    Pfeifer MA, Cook D, Brodsky I (1982) Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care 5: 518–528

  14. 14.

    Goldberg JM, Lindblom U (1979) Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry 42: 793–803

  15. 15.

    Oh SJ (1984) Clinical electromyography: nerve conduction studies. University Park Press, Baltimore, pp 93–113

  16. 16.

    Visser SL, Zonneveldt A, De Rijke W (1983) Normal Hoffmann reflex latencies (H-M interval) in relation to age and body length. Clin Neurol Neurosurg 85: 85–91

  17. 17.

    Trontelj JV, Stålberg E (1986) Axonal stimulation for end-plate studies. J Neurol Neurosurg Psychiatry 49: 677–683

  18. 18.

    Massey JM, Sanders DB (1991) Single-fiber EMG demonstrates reinnervation dynamics after nerve injury. Neurology 41: 1150–1151

  19. 19.

    Smith SA, Dewhurst R (1985) A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabetic Med 3: 38–41

  20. 20.

    Reulen JPH, Marcus JT, van Gilst MJ (1988) Stimulation and recording of dynamic pupillary reflex: the IRIS technique. Part 2. Med Biol Eng Comp 26: 27–32

  21. 21.

    de Vos A, Marcus JT, Reulen JPH, Peters HFM, Heimans JJ (1989) The pupillary light reflex in diabetes mellitus: evaluation of a newly developed infrared light reflection method. Diabetes Res 10: 191–195

  22. 22.

    Lanting P, Bos JE, Aartsen J, Schuman L, Reichert-Thoen J, Heimans JJ (1990) Assessment of pupillary light reflex latency and darkness adapted pupil size in control subjects and in diabetic patients with and without cardiovascular autonomic neuropathy. J Neurol Neurosurg Psychiatry 53: 912–914

  23. 23.

    Winer BJ (1962) Statistical principles in experimental design. McGraw-Hill, New York, pp 51–54

  24. 24.

    Thomas PK, Eliasson SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1773–1810

  25. 25.

    Boulton AJM, Knight G, Drury J, Ward JD (1985) The prevalence of symptomatic diabetes neuropathy in an insulin-treated population. Diabetes Care 8: 125–128

  26. 26.

    American Diabetes Association (1988) Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11: 592–597

  27. 27.

    Williams E, Timperley WR, Ward JD, Duckworth T (1980) Electron microscopic studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33: 462–470

  28. 28.

    Sima AAF, Brismar T (1985) Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 18: 21–29

  29. 29.

    Vracko R (1982) A comparison of microvascular lesions in diabetes mellitus with those of normal aging. J Am Geriatr Soc 30: 201–205

  30. 30.

    Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC (1980) Human diabetic endoneurial sorbitol, fructose and myoinositol related to sural nerve morphometry. Ann Neurol 8: 590–596

  31. 31.

    Dyck PJ, Hansen S, Karnes J (1985) Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82: 2513–2517

  32. 32.

    Chopra JS, Fannin T (1971) Pathology of diabetic neuropathy. J Pathol Bacteriol 104: 175–184

  33. 33.

    Behse F, Buchtal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40: 1072–1082

  34. 34.

    Kimura J, Yamada T, Stevland NP (1979) Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. J Neurol Sci 42: 291–302

  35. 35.

    Dyck PJ, Karnes JL, Daube J (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861–880

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hendriksen, P.H., Oey, P.L., Wieneke, G.H. et al. Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35, 690–695 (1992). https://doi.org/10.1007/BF00400264

Download citation

Key words

  • Diabetic neuropathy
  • Type 1 (insulin-depend-ent) diabetes mellitus
  • Type 2 (non-insulin-dependent) diabetes mellitus
  • comparative study